Carboplatin and Gemcitabine Chemotherapy for Malignant Pleural Mesothelioma: A Phase II Study of the GSTPV
- 1 August 1999
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 1 (1) , 73-75
- https://doi.org/10.3816/clc.1999.n.006
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Malignant pleural mesotheliomaAnnals of Oncology, 1998
- The National Cancer Data Base report on soft tissue sarcomaCancer, 1996
- Chemotherapy in malignant pleural mesothelioma. A review.Journal of Clinical Oncology, 1996
- Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.Journal of Clinical Oncology, 1993
- Clinical aspects of malignant mesothelioma in AustraliaAustralian and New Zealand Journal of Medicine, 1993
- Phase II trial of carboplatin in the management of malignant mesothelioma.Journal of Clinical Oncology, 1990
- Carboplatin in malignant mesothelioma: A phase II study of the cancer and leukemia Group BCancer Chemotherapy and Pharmacology, 1990
- Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.Journal of Clinical Oncology, 1989
- Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesotheliomaCancer Chemotherapy and Pharmacology, 1986